| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/18/2010 | US20100041654 Pyrimidine Derivatives And Their Use As CB2 Modulators |
| 02/18/2010 | US20100041653 Composition and methods for the design and development of metallo-enzyme inhibitors |
| 02/18/2010 | US20100041556 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides |
| 02/17/2010 | EP2153832A2 Heterocyclic aspartyl protease inhibitors |
| 02/17/2010 | EP2152701A1 Phenyl amino pyrimidine compounds and uses thereof |
| 02/17/2010 | EP2152672A1 Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors |
| 02/17/2010 | EP2152272A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| 02/17/2010 | EP2152271A1 Piperidine/piperazine derivatives |
| 02/17/2010 | EP2152079A1 Heterocyclic compounds and uses thereof |
| 02/17/2010 | CN101652353A 3-hydroquinazolin-4-one derivatives for use as stearoyl CoA desaturase inhibitors |
| 02/17/2010 | CN101652352A Quinazolines for PDK1 inhibition |
| 02/17/2010 | CN101652351A Pyrimidinyl-piperazines useful as d3/d2 receptor ligands |
| 02/17/2010 | CN101648947A 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 02/16/2010 | US7662938 2′-fluoronucleosides |
| 02/16/2010 | US7662828 Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds |
| 02/16/2010 | US7662821 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 02/16/2010 | US7662553 Polymorphisms in the ERCC1 gene for predicting treatment outcome |
| 02/16/2010 | CA2528008C 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2410399C 5-aminoalkylpyrazolo[4,3-d]pyrimidines |
| 02/16/2010 | CA2385081C Carboxylic acid compound and a medicament comprising it |
| 02/16/2010 | CA2341707C Pyrimidine derivatives |
| 02/11/2010 | WO2010017466A2 Phenobarbital salts; methods of making; and methods of use thereof |
| 02/11/2010 | WO2010017387A2 Lapatinib intermediates |
| 02/11/2010 | WO2008142550A9 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 02/11/2010 | WO2008044243A3 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 02/11/2010 | US20100036124 Preparation of azoxystrobin |
| 02/11/2010 | US20100036117 Pyrimidine compound and pests controlling composition containing the same |
| 02/11/2010 | US20100035907 New 2,4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 02/11/2010 | US20100035905 Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide |
| 02/11/2010 | US20100035904 Phenobarbital salts; methods of making; and methods of use thereof |
| 02/11/2010 | US20100035865 Sulfonamides and Pharmaceutical Compositions Thereof |
| 02/11/2010 | US20100034810 Pyrimidine derivatives for the prevention of hiv infection |
| 02/11/2010 | DE202009009917U1 Ambrisentan in spezifischer kristalliner Form Ambrisentan in specific crystalline form |
| 02/10/2010 | EP2151439A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same |
| 02/10/2010 | EP2151435A1 Pharmaceutical composition for treatment of alzheimer's disease |
| 02/10/2010 | EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 02/10/2010 | EP2150527A2 Anthranilic acid derivative as anticancer agent and a process for the preparation thereof |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | CN101646658A Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof |
| 02/10/2010 | CN101646657A Process for producing trichloropyrimidine compound |
| 02/10/2010 | CN101646656A Pyrimidine hydrazide compounds as PGDS inhibitors |
| 02/10/2010 | CN101643450A Synthesis method for multi substituted 2, 3-dihydro-4(1H)-pyrimidin thionone |
| 02/09/2010 | US7659307 Heterocyclic carboxamides and their use as fungicides |
| 02/09/2010 | US7659297 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 02/09/2010 | US7659279 2-{(2S)-2-[({4-[3-Chloro-4-fluoroanilino]-7-methoxyquinazolin-5-yl}oxy)methyl]pyrrolidin-1-yl}-2-oxoethanol; epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors; breast, colorectal and head and neck cancer |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | US7659271 N-{1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-N-({2-[(cyclopentylmethyl)(ethyl)amino]-5-(trifluoromethyl)phenyl}methyl)-5-[2-(methylthio)ethoxy]pyrimidin-2-amine; inhibitory activity on cholesterol ester transfer protein (CETP) |
| 02/09/2010 | US7659270 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/09/2010 | CA2451240C Cyclic diamine compound with 6 membered ring groups |
| 02/09/2010 | CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/09/2010 | CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 02/04/2010 | WO2010014939A1 Pyrimidine compounds, compositions and methods of use |
| 02/04/2010 | WO2010013827A1 Composition comprising phosphorescence emitting compound, and light emitting element using the composition |
| 02/04/2010 | WO2010013139A2 Radionuclide-labeled erlotinib |
| 02/04/2010 | WO2010012740A1 5-alkynyl-pyrimidines |
| 02/04/2010 | WO2010012442A2 Insecticidal benzenedicarboxamide derivative |
| 02/04/2010 | WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 02/04/2010 | US20100029940 Process for preparing rosuvastatin calcium |
| 02/04/2010 | US20100029699 Matrix metalloproteinase inhibitors |
| 02/04/2010 | US20100029695 Method of treating dermatitis comprising administering a chymase inhibitor |
| 02/04/2010 | US20100029694 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/04/2010 | US20100029689 Phosphodiesterase 4 inhibitors |
| 02/04/2010 | US20100029658 Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof |
| 02/04/2010 | US20100029612 2-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands |
| 02/04/2010 | US20100029610 Heteroaryl Compounds and Uses Thereof |
| 02/04/2010 | US20100029589 4,5-dihydro-oxazol-2yl derivatives |
| 02/04/2010 | CA2731909A1 5-alkynyl-pyrimidines |
| 02/03/2010 | EP2149565A1 Sulfoximine substituted chinazoline derivatives as immune modulators for the treatment of inflammatory and allergic diseases |
| 02/03/2010 | EP2149564A1 Substituted pyrimidine ether compounds and their use |
| 02/03/2010 | EP2149563A1 Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| 02/03/2010 | EP2148866A2 Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 02/03/2010 | CN101641339A Compounds for the prevention and treatment of cardiovascular diseases |
| 02/03/2010 | CN101641338A Multi-functional small molecules as anti-proliferative agents |
| 02/03/2010 | CN101641337A Compound for organic electroluminescent device and organic electroluminescent device |
| 02/03/2010 | CN101638391A 2-[(substituted aminobenzene)carbonylmethylthio]-6-(2,6-dichlorobenzyl)-3H-pyrimidyl-4-ketone derivative and preparation method and application thereof |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655796 Process for the preparation of rosuvstatin |
| 02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655651 Biphenyl-4-carboxylic acid (4-chloro-3-{7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl}-phenyl)-amide; protein kinase inhibitors |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 02/02/2010 | CA2434162C Reaction method utilizing diaphram type catalyst and apparatus therefor |
| 02/02/2010 | CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments |
| 01/28/2010 | WO2010009845A1 Sulfone substituted quinazoline derivatives as immune-modulators for the treatment of inflammatory and allergic diseases |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | WO2009140127A3 SYNTHESIS OF DIHYDROTHIENO[3,2-d]PYRIMIDINE DIOLS AND SIMILAR PYRIMIDINE DIOLS |
| 01/28/2010 | WO2009124962A3 Sulfonamides |
| 01/28/2010 | WO2009024251A4 Use of sulfonanilide compounds as herbicide |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022566 Quinazoline derivatives and pharmaceutical compositions thereof |
| 01/28/2010 | US20100022538 5-fluoro pyrimidine derivatives |
| 01/28/2010 | US20100022537 I-pheny 1-3,4-dihydropyrimidin-2(1h)-one derivatives and their use |
| 01/28/2010 | US20100022533 Compositions and methods for inducing cell dedifferentiation |
| 01/28/2010 | US20100022516 4,5-Disubstituted-2-aryl pyrimidines |
| 01/28/2010 | US20100022505 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof |
| 01/28/2010 | US20100019657 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/28/2010 | CA2731356A1 Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments |
| 01/27/2010 | EP2146964A2 Ethers of naphtalene carboxylic acid amides as cancer cure |